The EAU Research Foundation has published the following publications.

Search in Publications

Can zoledronic acid prevent bone metastases in high-risk non-metastatic prostate cancer patients? Efficacy and safety results of the Zometa European Study (ZEUS).

Wirth M, Tammela T, Cicalese V, Gomez Veiga F, Delaere K, Miller K, Tubaro A, Schulze M, Debruyne F, Huland H, Patel A, Lecouvet F, Caris C, Witjes W. A prospective, randomized, open-label, multi-national study of the European Association of Urology (EAU) in co-operation with the Scandinavian Prostate Cancer Group (SPCG) and the Arbeitsgemeinschaft für Urologische Onkologie (AUO).

A randomized, double blind, placebo controlled phase II trial to evaluate the safety and efficacy of recMAGE-A3 + AS15 antigen specific cancer immunotherapy in patients with MAGE-A3 positive muscle invasive bladder cancer after cystectomy

P.F.A. Mulders, M. Colombel, A. Heidenreich, L. Martínez-Piñeiro, M. Babjuk, I. Korneyev, C. Surcel, P. Yakovlev, R. Colombo, P. Radziszewski, J.A. Witjes, R. Schipper, W.P.J. Witjes. An initial report of the EAU Research Foundation randomized phase II clinical trial ‘Magnolia’.